Applied Genetic Technologies Corp operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Applied Genetic Technologies Corp with three other
companies in this sector in the United States:
sales of $13.30 million
of which 77%
was Bronchitol and Aridol),
Arrowhead Pharmaceuticals Inc
of which 100%
was Research & Development), and
Bioanalytical Systems, Inc.
Applied Genetic Technologies Corp reported sales of $39.47 million
June of 2017.
decrease of 16.7%
versus 2016, when the company's sales were $47.36 million.